AbbVie Inc. ABBV
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 17.40B | 16.99B | 15.00B | 16.62B | 15.78B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.40B | 16.99B | 15.00B | 16.62B | 15.78B |
| Cost of Revenue | 4.29B | 4.29B | 4.22B | 4.55B | 4.46B |
| Gross Profit | 13.12B | 12.70B | 10.78B | 12.07B | 11.32B |
| SG&A Expenses | 3.80B | 3.55B | 3.49B | 3.82B | 3.43B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -18.00M | 0.00 | -- | 0.00 | -- |
| Total Operating Expenses | 10.51B | 10.19B | 10.18B | 10.95B | 10.18B |
| Operating Income | 6.89B | 6.80B | 4.82B | 5.67B | 5.60B |
| Income Before Tax | 4.83B | 4.28B | 1.04B | 2.67B | 714.00M |
| Income Tax Expenses | 609.00M | 662.00M | 342.00M | 853.00M | 526.00M |
| Earnings from Continuing Operations | 4.22B | 3.62B | 697.00M | 1.82B | 188.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -2.00M | -3.00M | -2.00M | 1.00M | -2.00M |
| Net Income | 4.22B | 3.61B | 695.00M | 1.82B | 186.00M |
| EBIT | 6.89B | 6.80B | 4.82B | 5.67B | 5.60B |
| EBITDA | 8.75B | 8.69B | 6.76B | 7.66B | 7.66B |
| EPS Basic | 2.38 | 2.04 | 0.39 | 1.02 | 0.10 |
| Normalized Basic EPS | 2.19 | 2.14 | 1.48 | 1.81 | 1.81 |
| EPS Diluted | 2.37 | 2.03 | 0.39 | 1.02 | 0.10 |
| Normalized Diluted EPS | 2.18 | 2.14 | 1.47 | 1.81 | 1.80 |
| Average Basic Shares Outstanding | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B |
| Average Diluted Shares Outstanding | 1.77B | 1.77B | 1.78B | 1.77B | 1.77B |
| Dividend Per Share | 1.73 | 1.73 | 1.73 | 1.73 | 1.64 |
| Payout Ratio | 72.81% | 84.97% | 444.03% | 160.30% | 1,565.05% |